Cargando…

The tetraamine chelator outperforms HYNIC in a new technetium-99m-labelled somatostatin receptor 2 antagonist

BACKGROUND: Somatostatin receptor targeting radiopeptides are successfully being used to image, stage, and monitor patients with neuroendocrine tumours. They are exclusively agonists that internalise upon binding to the relevant receptor. According to recent reports, antagonists may be preferable to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abiraj, Keelara, Ursillo, Samer, Tamma, Maria Luisa, Rylova, Svetlana N., Waser, Beatrice, Constable, Edwin C., Fani, Melpomeni, Nicolas, Guillaume P., Reubi, Jean Claude, Maecke, Helmut R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070450/ https://www.ncbi.nlm.nih.gov/pubmed/30069789 http://dx.doi.org/10.1186/s13550-018-0428-y

Ejemplares similares

The somatostatin receptor 2 antagonist (64)Cu-NODAGA-JR11 outperforms (64)Cu-DOTA-TATE in a mouse xenograft model
por: Rylova, Svetlana N., et al.
Publicado: (2018)

SPECT Imaging of SST2-Expressing Tumors with (99m)Tc-Based Somatostatin Receptor Antagonists: The Role of Tetraamine, HYNIC, and Spacers
por: Gaonkar, Raghuvir Haridas, et al.
Publicado: (2021)

Evolution of Bombesin Conjugates for Targeted PET Imaging of Tumors
por: Zhang, Hanwen, et al.
Publicado: (2012)

Synthesis and antimicrobial evaluation of two peptide LyeTx I derivatives modified with the chelating agent HYNIC for radiolabeling with technetium-99m
por: Fuscaldi, Leonardo Lima, et al.
Publicado: (2016)

Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m
por: Klingler, Maximilian, et al.
Publicado: (2019)

Value of Somatostatin Receptor Scintigraphy with (99m)Tc-HYNIC-TOC in Patients with Primary Sjögren Syndrome
por: Anzola, Luz Kelly, et al.
Publicado: (2019)

Biphenyl-3,3′,4,4′-tetraamine
por: Qian, Hui-Fen, et al.
Publicado: (2010)

Vascular Response of Ruthenium Tetraamines in Aortic Ring from Normotensive Rats
por: Conceição-Vertamatti, Ana Gabriela, et al.
Publicado: (2015)

Influence of Temperature on the Enantioselectivity of Koga Tetraamines on Amylose Chiral Stationary Phases
por: Guo, Hong-Xun, et al.
Publicado: (2013)

Somatostatin Receptor SPECT/CT using (99m)Tc Labeled HYNIC-TOC Aids in Diagnosis of Primary Optic Nerve Sheath Meningioma
por: Chandra, Piyush, et al.
Publicado: (2017)

Distribution of somatostatin receptors in normal and neoplastic human tissues: recent advances and potential relevance.
por: Reubi, J. C., et al.
Publicado: (1997)

Radiolabeled Somatostatin Analogs—A Continuously Evolving Class of Radiopharmaceuticals
por: Fani, Melpomeni, et al.
Publicado: (2022)

Click-to-Chelate: Development of Technetium and Rhenium-Tricarbonyl Labeled Radiopharmaceuticals
por: Kluba, Christiane A., et al.
Publicado: (2013)

Somatostatin receptors in the gastrointestinal tract in health and disease.
por: Reubi, J. C.
Publicado: (1992)

Evaluation of a New (177)Lu-Labeled Somatostatin Analog for the Treatment of Tumors Expressing Somatostatin Receptor Subtypes 2 and 5
por: Mansi, Rosalba, et al.
Publicado: (2020)

Technetium-99m chelator-free radiolabeling of specific glutamine tumor imaging nanoprobe: in vitro and in vivo evaluations
por: Ghoreishi, Seyedeh Masoumeh, et al.
Publicado: (2018)

(99m)Tc-Hynic-TOC imaging in the diagnostic of neuroendocrine tumors
por: Liepe, Knut, et al.
Publicado: (2018)

A new (68)Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting
por: Mansi, Rosalba, et al.
Publicado: (2020)

Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13
por: Klingler, Maximilian, et al.
Publicado: (2019)

The Diagnostic Efficiency of 99mTc-EDDA/HYNIC-Octreotate SPECT-CT in Comparison with 111In-Pentetrotide in the Detection of Neuroendocrine Tumours
por: Koçyiğit Deveci, Emel, et al.
Publicado: (2013)

Development of a hydroxamamide-based bifunctional chelating agent to prepare technetium-99m-labeled bivalent ligand probes
por: Shimizu, Yoichi, et al.
Publicado: (2021)

Diagnosis of bone infection by complementary role of technetium-99m MDP and technetium-99m hexamethylpropylene-amineoxime-leukocytes
por: Al-Zahrani, Abdullah, et al.
Publicado: (2012)

Patient-specific dosimetry of (99m)Tc-HYNIC-Tyr(3)-Octreotide in children
por: Hou, Xinchi, et al.
Publicado: (2017)

Predictive Value of 99MTC-hynic-toc Scintigraphy in Lung Neuroendocrine Tumor Diagnosis
por: Boutsikou, Efimia, et al.
Publicado: (2019)

Evaluation of Radiation dosimetry of (99m)Tc-HYNIC-PSMA and imaging in prostate cancer
por: Zhang, Jianping, et al.
Publicado: (2020)

Distinct In Vitro Binding Profile of the Somatostatin Receptor Subtype 2 Antagonist [(177)Lu]Lu-OPS201 Compared to the Agonist [(177)Lu]Lu-DOTA-TATE
por: Mansi, Rosalba, et al.
Publicado: (2021)

[(111)In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study
por: Tatsi, Aikaterini, et al.
Publicado: (2012)

(99m)Tc-Labeled HYNIC-DAPI Causes Plasmid DNA Damage with High Efficiency
por: Kotzerke, Joerg, et al.
Publicado: (2014)

Hybridised production of technetium-99m and technetium-101 with fluorine-18 on a low-energy biomedical cyclotron
por: Johnstone, Erik V., et al.
Publicado: (2023)

Technetium-99m production issues in the United Kingdom
por: Green, Christopher H.
Publicado: (2012)

Selection of the First (99m)Tc-Labelled Somatostatin Receptor Subtype 2 Antagonist for Clinical Translation—Preclinical Assessment of Two Optimized Candidates
por: Fani, Melpomeni, et al.
Publicado: (2020)

AIP-mutated acromegaly resistant to first-generation somatostatin analogs: long-term control with pasireotide LAR in two patients
por: Daly, Adrian F, et al.
Publicado: (2019)

(99m)Tc-HYNIC-Annexin A5 in Oncology: Evaluating Efficacy of Anti-Cancer Therapies
por: Schaper, Frédéric L.W.V.J., et al.
Publicado: (2013)

Author Correction: Evaluation of Radiation dosimetry of (99m)Tc-HYNIC-PSMA and imaging in prostate cancer
por: Zhang, Jianping, et al.
Publicado: (2020)

Diagnostic accuracy of (99m)Tc-HYNIC-TOC SPECT/CT for detecting osteomalacia-associated tumors
por: Li, Bo, et al.
Publicado: (2023)

Comparison of 99mTc radiolabeled somatostatin antagonist with [(68) Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor
por: Opalinska, Marta, et al.
Publicado: (2023)

Clinical value of technetium-99m-labeled octreotide scintigraphy in local recurrent or metastatic medullary thyroid cancers: a comparison of lesions with (18)F-FDG-PET and MIBI images
por: Sager, Sait, et al.
Publicado: (2013)

(99m)Technetium Sestamibi-(123)Iodine Scintigraphy Is More Accurate Than (99m)Technetium Sestamibi Alone before Surgery for Primary Hyperparathyroidism
por: Ryhänen, Eeva M., et al.
Publicado: (2015)

Options for UK Technetium-99m Production using Accelerators
por: H.L. Owen, et al.
Publicado: (2014)

Recent Levels of Technetium-99 in Seawater at the West Coast of Svalbard
por: Gerland, Sebastian, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_4uvlorc060gae9eokve9idaec9